Loading...
biote Corp.
BTMD•NASDAQ
Healthcare
Medical - Care Facilities
$4.32
$0.16(3.85%)
biote Corp. (BTMD) Financial Performance & Income Statement Overview
Review biote Corp.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
6.38%
↑ 6.38%
Operating Income Growth
10.31%
↑ 10.31%
Net Income Growth
-4.79%
↓ 4.79%
Operating Cash Flow Growth
68.30%
↑ 68.30%
Operating Margin
15.49%
↑ 15.49%
Gross Margin
71.22%
↑ 71.22%
Net Profit Margin
10.93%
↑ 10.93%
ROE
-18.92%
↓ 18.92%
ROIC
41.22%
↑ 41.22%
biote Corp. (BTMD) Income Statement & Financial Overview
Review biote Corp.'s (BTMD) income statement with detailed quarterly and annual figures.
| Metric | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $51.38M | $49.17M | $46.80M | $45.70M |
| Cost of Revenue | $15.17M | $15.29M | $14.12M | $15.52M |
| Gross Profit | $36.21M | $33.88M | $32.69M | $30.19M |
| Gross Profit Ratio | $0.70 | $0.69 | $0.70 | $0.66 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $24.03M | $27.65M | $22.26M | $20.12M |
| Operating Expenses | $24.03M | $27.65M | $22.26M | $20.12M |
| Total Costs & Expenses | $39.20M | $42.94M | $36.38M | $35.63M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $3.54M | $2.58M | $1.66M | $1.54M |
| Depreciation & Amortization | $0.00 | $876000.00 | $750000.00 | $1.51M |
| EBITDA | $12.18M | -$6.84M | -$914000.00 | $12.39M |
| EBITDA Ratio | $0.24 | -$0.14 | $0.24 | $0.25 |
| Operating Income | $12.18M | $6.23M | $10.43M | $10.07M |
| Operating Income Ratio | $0.24 | $0.13 | $0.22 | $0.22 |
| Other Income/Expenses (Net) | $3.67M | -$16.53M | -$13.75M | $3.83M |
| Income Before Tax | $15.86M | -$10.29M | -$3.32M | $9.33M |
| Income Before Tax Ratio | $0.31 | -$0.21 | -$0.07 | $0.20 |
| Income Tax Expense | $3.20M | $180000.00 | $2.49M | -$2.74M |
| Net Income | $10.70M | -$6.32M | -$2.07M | $7.73M |
| Net Income Ratio | $0.21 | -$0.13 | -$0.04 | $0.17 |
| EPS | $0.34 | -$0.19 | -$0.06 | $0.23 |
| Diluted EPS | $0.33 | -$0.19 | -$0.06 | $0.12 |
| Weighted Avg Shares Outstanding | $31.05M | $33.07M | $34.62M | $33.98M |
| Weighted Avg Shares Outstanding (Diluted) | $32.26M | $33.07M | $34.62M | $63.35M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan